HYPERTROPHIC CARDIOMYOPATHY

[1] NOONAN SYNDROME - THE CHANGING PHENOTYPE [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 21 (03): : 507 - 514

[2] CARDIOLOGIC ABNORMALITIES IN NOONAN SYNDROME - PHENOTYPIC DIAGNOSIS AND ECHOCARDIOGRAPHIC ASSESSMENT OF 118 PATIENTS [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : 1189 - 1192

[3] BURCH M, 1992, BRIT HEART J, V68, P586

[4] ABNORMAL VASCULAR-RESPONSES TO SUPINE EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY [J]. CIRCULATION, 1991, 84 (02) : 686 - 696

[5] MITOCHONDRIAL MYOPATHIES [J]. ANNALS OF NEUROLOGY, 1985, 17 (06) : 521 - 538

[6] DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J]. CIRCULATION, 1992, 86 (02) : 345 - 352

[7] EVIDENCE OF GENETIC-HETEROGENEITY IN 5 KINDREDS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J]. CIRCULATION, 1992, 85 (02) : 635 - 647

[8] PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J]. CIRCULATION, 1992, 86 (03) : 730 - 740

[9] SUDDEN-DEATH DURING EMPIRIC AMIODARONE THERAPY IN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (02) : 169 - 174

[10] A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J]. CELL, 1990, 62 (05) : 999 - 1006

[1] NOONAN SYNDROME - THE CHANGING PHENOTYPE [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 21 (03): : 507 - 514

[2] CARDIOLOGIC ABNORMALITIES IN NOONAN SYNDROME - PHENOTYPIC DIAGNOSIS AND ECHOCARDIOGRAPHIC ASSESSMENT OF 118 PATIENTS [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (04) : 1189 - 1192

[3] BURCH M, 1992, BRIT HEART J, V68, P586

[4] ABNORMAL VASCULAR-RESPONSES TO SUPINE EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY [J]. CIRCULATION, 1991, 84 (02) : 686 - 696

[5] MITOCHONDRIAL MYOPATHIES [J]. ANNALS OF NEUROLOGY, 1985, 17 (06) : 521 - 538

[6] DIFFERENCES IN CLINICAL EXPRESSION OF HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH 2 DISTINCT MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE - A 908LEU-]VAL MUTATION AND A 403ARG-]GLN MUTATION [J]. CIRCULATION, 1992, 86 (02) : 345 - 352

[7] EVIDENCE OF GENETIC-HETEROGENEITY IN 5 KINDREDS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J]. CIRCULATION, 1992, 85 (02) : 635 - 647

[8] PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY - PROSPECTIVE EVALUATION OF A THERAPEUTIC STRATEGY BASED ON CLINICAL, HOLTER, HEMODYNAMIC, AND ELECTROPHYSIOLOGICAL FINDINGS [J]. CIRCULATION, 1992, 86 (03) : 730 - 740

[9] SUDDEN-DEATH DURING EMPIRIC AMIODARONE THERAPY IN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (02) : 169 - 174

[10] A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J]. CELL, 1990, 62 (05) : 999 - 1006